OR WAIT null SECS
August 13, 2021
The agency has amended the emergency use authorizations for the Pfizer-BioNTech and Moderna vaccines to allow certain immunocompromised people to receive an additional dose of the vaccine.
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.
August 12, 2021
A research team at the Keck Graduate Institute will work to adapt its decade-long low-cost vaccine R&D for developing countries into a COVID-19 vaccine.
FDA has awarded Fast Track designation to Vivet Therapeutics’ novel gene therapy, VTX-801.
A collaboration between Aldevron and Ginkgo Bioworks has resulted in a manufacturing enhancement that can improve production of an enzyme used for mRNA therapeutics.
Veraxa and Indivumed will work together to develop colorectal antibody drugs.
Lonza and Sheba Medical Center have successfully dosed four patients with a CD19 autologous CAR-T cell therapy using Lonza’s Cocoon automated manufacturing platform.
Moderna will build an mRNA vaccine manufacturing facility in Canada to provide access to domestically manufactured vaccines against respiratory viruses.
The Just - Evotec Biologics facility in Redmond, Wash., uses the company’s J.POD technology.
The EC has approved the drug in the EU for treatment of chronic kidney disease in adults with or without type-2 diabetes.